Geneos Therapeutics Funding: $40M Raised, Series A (2022)
Geneos Therapeutics is based in Plymouth Meeting, Pennsylvania. It has raised $40M in total funding. Latest round: Series A.
Geneos Therapeutics funding overview
Geneos Therapeutics is based in Plymouth Meeting, Pennsylvania. Geneos Therapeutics has raised $40M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in March 2022. The round record for Geneos Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Flerie Invest, Santé·· Ventures, Korea Investment Partners, INOVIO Pharmaceuticals. 4 distinct backers are named across the disclosed rounds.
Geneos Therapeutics at a glance
Total raised
$40M
Latest round
Series A
Latest round date
March 2022
Headquarters
Plymouth Meeting, Pennsylvania
Notable investors
Flerie Invest, Santé·· Ventures, Korea Investment Partners, INOVIO Pharmaceuticals
Frequently asked about Geneos Therapeutics funding
How much has Geneos Therapeutics raised?
Geneos Therapeutics has raised $40M in total disclosed funding across the rounds on record.
Who has invested in Geneos Therapeutics?
Flerie Invest, Santé·· Ventures, Korea Investment Partners, INOVIO Pharmaceuticals are named among the investors backing Geneos Therapeutics.
What was the latest Geneos Therapeutics funding round?
The most recent disclosed round is a Series A, announced in March 2022.
Where is Geneos Therapeutics based?
Geneos Therapeutics is based in Plymouth Meeting, Pennsylvania.
When did Geneos Therapeutics last raise?
The last disclosed Geneos Therapeutics round closed in March 2022 at Series A.
We update the Geneos Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Plymouth Meeting and their backers are listed below.
